β-Blockers as Antiarrhythmic Agents

Handbook of Experimental Pharmacology

Volumn 171, Issue , 2006, Pages 235-266

  Zicha, S ^a   Tsuji, Y ^a   Shiroshita Takeshita, A ^a   Nattel, S ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Adrenergic receptors; Adrenoceptor antagonists; G protein coupled receptors; Long QT syndrome; Sudden cardiac death

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CHLORIDE CHANNEL; POTASSIUM CHANNEL; SODIUM CALCIUM EXCHANGE PROTEIN;

ACTION POTENTIAL; ANIMAL; DRUG EFFECT; HEART; HEART ARRHYTHMIA; HUMAN; PHYSIOLOGY; REVIEW;

ACTION POTENTIALS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CALCIUM CHANNELS, L-TYPE; CHLORIDE CHANNELS; HEART; HUMANS; POTASSIUM CHANNELS; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SODIUM-CALCIUM EXCHANGER;

EID: 33646008587     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-29715-4-9     Document Type: Article

References (175)

1. Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA (1999) MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97:175-187
2. Ackerman MJ, Clapham DE (1997) Ion channels-basic science and clinical disease. N Engl J Med 336:1575-1586
3. Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153:586-600
4. Anonymous (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304:801-807
5. Anonymous (1982) A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247:1707-1714
6. Anonymous (1999a) Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001-2007
7. Anonymous (1999b) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353:9-13
8. Antzelevitch C (2003) Molecular genetics of arrhythmias and cardiovascular conditions associated with arrhythmias. Pacing Clin Electrophysiol 26:2194-2208
9. Arch JR, Kaumann AJ (1993) Beta 3 and atypical beta-adrenoceptors. Med Res Rev 13:663-729
10. Bahinski A, Nairn AC, Greengard P, Gadsby DC (1989) Chloride conductance regulated by cyclic AMP-dependent protein kinase in cardiac myocytes. Nature 340:718-721
11. Barcroft H, Talbot JF (1968) Oliver and Schafers discovery of the cardiovascular action of suprarenal extract. Postgrad Med J 44:6-8
12. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G (1996) K (V)LQT1 and lsK (minK) proteins associate to form the I (Ks) cardiac potassium current. Nature 384:78-80
13. Belardinelli L, Isenberg G (1983) Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 53:287-297
14. Beuckelmann DJ, Nabauer M, Erdmann E (1993) Alterations of K+ currents in isolated human ventricularmyocytes frompatients with terminal heart failure. Circ Res 73:379-385
15. Bigger JT Jr (1985) Digitalis toxicity. J Clin Pharmacol 25:514-521
16. Bohm M, Diet F, Feiler G, Kemkes B, Erdmann E (1988) Alpha-adrenoceptors and alphaadrenoceptor- mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol 12:357-364
17. Bonet S, Agusti A, Arnau JM, Vidal X, Diogene E, Galve E, Laporte JR (2000) Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients characteristics: a meta-analysis of clinical trials. Arch Intern Med 160:621-627
18. Boutitie F, Boissel JP, Connolly SJ, CammAJ, Cairns JA, JulianDG, GentM, JanseMJ, DorianP, Frangin G (1999) Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (EuropeanMyocardial Infarct Amiodarone Trial) andCAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. Circulation 99:2268-2275
19. BristowMR, MinobeWA, RaynoldsMV, Port JD, Rasmussen R, Ray PE, FeldmanAM (1993) Reduced beta 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest 92:2737-2745
20. BroddeOE (1991)Beta 1- andbeta 2-adrenoceptors in thehumanheart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203-242
21. Brodde OE, Vogelsang M, Broede A, Michel-Reher M, Beisenbusch-Schafer E, Hakim K, Zerkowski HR (1998) Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 31:585-594
22. Burnell RH, Maxwell GM (1971) The cardiovascular effects of terbutaline. Eur J Pharmacol 15:383-385
23. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136
24. Cairns JA, Connolly SJ, Roberts R, Gent M (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian AmiodaroneMyocardial Infarction Arrhythmia Trial Investigators. Lancet 349:675-682
25. Cameron JS, Myerburg RJ, Wong SS, Gaide MS, Epstein K, Alvarez TR, Gelband H, Guse PA, Bassett AL (1983) Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overload. J Am Coll Cardiol 2:481-487
26. CASTInvestigators (1989)Preliminary report: effect of encainide and flecainide onmortality in a randomized trial of arrhythmia suppression aftermyocardial infarction.The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 321:406-412
27. Chen SA, Chiang CE, Yang CJ, Cheng CC, Wu TJ, Wang SP, Chiang BN, Chang MS (1994) Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation 90:1262-1278
28. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS (1999) Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100:1879-1886
29. Cleophas TJ, Zwinderman AH (2001) Beta-blockers and heart failure: meta-analysis of mortality trials. Int J Clin Pharmacol Ther 39:383-388
30. Connolly SJ, Cybulsky I, Lamy A, Roberts RS, OBrien B, Carroll S, Crystal E, Thorpe KE, Gent M (2003) Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study. Am Heart J 145:226-232
31. Courtemanche M, Ramirez RJ, Nattel S (1999) Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights fromamathematical model. Cardiovasc Res 42:477-489
32. CranefieldPF (1977)Actionpotentials, afterpotentials, andarrhythmias. CircRes 41:415-423
33. Cranefield PF, Wit AL, Hoffman BF (1973) Genesis of cardiac arrhythmias. Circulation 47:190-204
34. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S (2002) Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 106:75-80
35. Cui J, Melman Y, Palma E, Fishman GI, McDonald TV (2000) Cyclic AMP regulates the HERG K (+) channel by dual pathways. Curr Biol 10:671-674
36. Curran ME, Splawski I, TimothyKW, VincentGM, GreenED, KeatingMT (1995)Amolecular basis for cardiac arrhythmia: HERGmutations cause longQT syndrome. Cell 80:795-803
37. De Ferrari GM, Viola MC, DAmato E, Antolini R, Forti S (1995)Distinct patterns of calcium transients during early and delayed afterdepolarizations induced by isoproterenol in ventricular myocytes. Circulation 91:2510-2515
38. De Rosa G, Delogu AB, Piastra M, Chiaretti A, Bloise R, Priori SG (2004) Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol. Pediatr Emerg Care 20:175-177
39. DiFrancesco D (1993) Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol 55:455-472
40. Dixon RA, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, Bolanowski MA, Bennett CD, Rands E, Diehl RE (1986) Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 321:75-79
41. Dresel PE (1960) Blockade of some cardiac actions of adrenaline by dichloroisoproterenol. Can J Med Sci 38:375-381
42. DzimiriN (1999)Regulation of beta-adrenoceptor signaling in cardiac function and disease. Pharmacol Rev 51:465-501
43. Egan TM, Noble D, Noble SJ, Powell T, Twist VW, Yamaoka K (1988) On the mechanism of isoprenaline- and forskolin-induced depolarization of single guinea-pig ventricular myocytes. J Physiol 400:299-320
44. Eichhorn EJ, Bristow MR (1996) Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 94:2285-2296
45. Eichhorn EJ, Bristow MR (2001) The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Curr Control Trials Cardiovasc Med 2:20-23
46. Engelhardt S, Bohm M, Erdmann E, Lohse MJ (1996) Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol 27:146-154
47. Fabiato A, Fabiato F (1975) Contractions induced by a calcium-triggered release of calcium from the sarcoplasmic reticulum of single skinned cardiac cells. J Physiol 249:469-495
48. Fakler B, Brandle U, Glowatzki E, Zenner HP, Ruppersberg JP (1994) Kir2.1 inward rectifier K+channels are regulated independently by protein kinases andATP hydrolysis.Neuron 13:1413-1420
49. Fedida D, Wible B, Wang Z, Fermini B, Faust F, Nattel S, Brown AM (1993) Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current. Circ Res 73:210-216
50. Feng J, Wible B, Li GR, Wang Z, Nattel S (1997) Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes. Circ Res 80:572-579
51. Freemantle N, Cleland J, Young P, Mason J, Harrison J (1999) beta Blockade aftermyocardial infarction: systematic review and meta regression analysis. BMJ 318:1730-1737
52. Gaspo R, Bosch RF, Talajic M, Nattel S (1997) Functional mechanisms underlying tachycardia- induced sustained atrial fibrillation in a chronic dog model. Circulation 96:4027-4035
53. Gelband H, Bassett AL (1973) Depressed transmembrane potentials during experimentally induced ventricular failure in cats. Circ Res 32:625-634
54. Goldstein S, Hjalmarson A (1999) The mortality effect of metoprolol CR/XL in patients with heart failure: results of the MERIT-HF Trial. Clin Cardiol 22 Suppl 5:V30-V35
55. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, LeMetayer P, Clementy J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659-666
56. HakimK, FischerM, Gunnicker M, PoenickeK, ZerkowskiHR, BroddeOE (1997) Functional role of beta2-adrenoceptors in the transplanted human heart. J Cardiovasc Pharmacol 30:811-816
57. Han W, Chartier D, Li D, Nattel S (2001a) Ionic remodeling of cardiac Purkinje cells by congestive heart failure. Circulation 104:2095-2100
58. HanW, Wang Z, Nattel S (2001b) Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells. Am J Physiol Heart Circ Physiol 280:H1075-H1080
59. Harvey RD, Hume JR (1989) Autonomic regulation of a chloride current in heart. Science 244:983-985
60. Hauswirth O, NobleD, Tsien RW (1968) Adrenaline: mechanism of action on the pacemaker potential in cardiac Purkinje fibers. Science 162:916-917
61. Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, Ross J Jr (1990) Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 65:547-553
62. Hohnloser SH (1997) Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management. Am J Cardiol 80:82G-89G
63. Hume JR, Duan D, Collier ML, Yamazaki J, Horowitz B (2000) Anion transport in heart. Physiol Rev 80:31-81
64. Hwang TC, Horie M, Nairn AC, Gadsby DC (1992) Role of GTP-binding proteins in the regulation of mammalian cardiac chloride conductance. J Gen Physiol 99:465-489
65. Ihl-Vahl R, Eschenhagen T, Kubler W, Marquetant R, Nose M, Schmitz W, Scholz H, Strasser RH (1996) Differential regulation of mRNA specific for beta 1- and beta 2- adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods. J Mol Cell Cardiol 28:1-10
66. ISIS Collaborative Group (1986) Randomised trial of intravenous atenolol among 16 027 cases of suspected acutemyocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 2:57-66
67. ISIS Collaborative Group (1988)Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Lancet 1:921-923
68. Janse MJ, Wit AL (1989) Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 69:1049-1169
69. 2+ current. Circ Res 64:977-990
70. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P (1997) Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 349:667-674
71. Kaab S, Nuss HB, Chiamvimonvat N, ORourke B, Pak PH, Kass DA, Marban E, Tomaselli GF (1996) Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 78:262-273
72. Katz AM (2003) Pathophysiology of heart failure: identifying targets for pharmacotherapy. Med Clin North Am 87:303-316
73. Katzung BG, Morgenstern JA (1977) Effects of extracellular potassium on ventricular automaticity and evidence for a pacemaker current in mammalian ventricularmyocardium. Circ Res 40:105-111
74. Kaumann AJ (1996) (?)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor. Br J Pharmacol 117:93-98
75. Kaumann AJ, Hall JA, Murray KJ, Wells FC, Brown MJ (1989) A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 10 Suppl B:29-37
76. Keating MT, SanguinettiMC (2001)Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104:569-580
77. Kelman GR, Palmer KN, Cross MR (1969) Cardiovascular effects of AH.3365 (salbutamol). Nature 221:1251
78. Khan MI, Hamilton JT, ManningGW (1972) Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs. Am J Cardiol 30:832-837
79. Kjekshus JK (1986) Importance of heart rate in determining beta-blocker efficacy in acute and long-termacute myocardial infarction intervention trials. Am J Cardiol 57:43F-49F
80. Kleiman RB, Houser SR (1989) Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol 256:H1450-H1461
81. Koumi S, Backer CL, Arentzen CE, Sato R (1995a) beta-Adrenergic modulation of the inwardly rectifying potassiumchannel in isolated human ventricularmyocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts. J Clin Invest 96:2870-2881
82. Koumi S, WasserstromJA, Ten EickRE (1995b) beta-Adrenergic and cholinergicmodulation of the inwardly rectifying K+ current in guinea-pig ventricular myocytes. J Physiol 486:647-659
83. KuhlkampV, Schirdewan A, Stangl K, Homberg M, Ploch M, BeckOA (2000)Use ofmetoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 36:139-146
84. 2+ release in the heart. Cardiovasc Res 26:193-214
85. Lazzara R, Scherlag BJ (1988) Generation of arrhythmias in myocardial ischemia and infarction. Am J Cardiol 61:20A-26A
86. Lee CO, Kang DH, Sokol JH, Lee KS (1980) Relation between intracellular Na ion activity and tension of sheep cardiac Purkinje fibers exposed to dihydro-ouabain. Biophys J 29:315-330
87. Leenen FH, Davies RA, Fourney A (1998) Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade. Clin Pharmacol Ther 64:522-535
88. Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A, Nattel S (2000) Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 101:2631-2638
89. Li GR, Feng J, Wang Z, Fermini B, Nattel S (1996a) Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes. Circ Res 78:903-915
90. Li GR, Feng J, Wang Z, Nattel S (1996b) Transmembrane chloride currents in human atrial myocytes. Am J Physiol 270:C500-C507
91. Li GR, Lau CP, Ducharme A, Tardif JC, Nattel S (2002) Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am J Physiol Heart Circ Physiol 283:H1031-H1041
92. Litovsky SH, Antzelevitch C (1988) Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res 62:116-126
93. Liu DW, Antzelevitch C (1995) Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. A weaker IKs contributes to the longer action potential of the M cell. Circ Res 76:351-365
94. Luo CH, Rudy Y (1994) A dynamic model of the cardiac ventricular action potential. II. Afterdepolarizations, triggered activity, and potentiation. Circ Res 74:1097-1113
95. Malfatto G, Rosen TS, Rosen MR (1988) The response to overdrive pacing of triggered atrial and ventricular arrhythmias in the canine heart. Circulation 77:1139-1148
96. MarxSO, Kurokawa J, Reiken S, MotoikeH, DArmiento J, MarksAR, KassRS (2002)Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295:496-499
97. Matsuoka S, Ehara T, Noma A (1990) Chloride-sensitive nature of the adrenaline-induced current in guinea-pig cardiac myocytes. J Physiol 425:579-598
98. McDevitt DG (1989) In vivo studies on the function of cardiac beta-adrenoceptors in man. Eur Heart J 10 Suppl B:22-28
99. Moroni A, Gorza L, Beltrame M, Gravante B, Vaccari T, Bianchi ME, Altomare C, Longhi R, Heurteaux C, Vitadello M, Malgaroli A, DiFrancesco D (2001) Hyperpolarization-activated cyclic nucleotide-gated channel 1 is a molecular determinant of the cardiac pacemaker current I (f). J Biol Chem 276:29233-29241
100. Moss AJ, ZarebaW, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML (2000) Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101:616-623
101. Motomura S, Reinhard-Zerkowski H, Daul A, Brodde OE (1990) On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies. Am Heart J 119:608-619
102. Nakayama T, Fozzard HA (1988) Adrenergic modulation of the transient outward current in isolated canine Purkinje cells. Circ Res 62:162-172
103. Nattel S (2000) Acquired delayed rectifier channelopathies: how heart disease and antiarrhythmic drugs mimic potentially-lethal congenital cardiac disorders. Cardiovasc Res 48:188-190
104. Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature 415:219-226
105. Nattel S (2003) Rhythm versus rate control for atrial fibrillation management: what recent randomized clinical trials allow us to affirm. CMAJ 168:572-573
106. Nattel S, Li D (2000) Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ Res 87:440-447
107. Nattel S, QuantzMA (1988) Pharmacological response of quinidine induced early afterdepolarisations in canine cardiac Purkinje fibres: insights into underlying ionic mechanisms. Cardiovasc Res 22:808-817
108. Nattel S, WatersD (1990)What isanantiarrhythmicdrug?Fromclinical trials tofundamental concepts. Am J Cardiol 66:96-99
109. Nattel S, Khairy P, Roy D, Thibault B, Guerra P, Talajic M, Dubuc M (2002) New approaches to atrial fibrillation management: a critical review of a rapidly evolving field. Drugs 62:2377-2397
110. Nordin C, Siri F, Aronson RS (1989) Electrophysiologic characteristics of single myocytes isolated from hypertrophied guinea-pig hearts. J Mol Cell Cardiol 21:729-739
111. Nuttall A, SnowHM (1982) The cardiovascular effects of ICI 118, 587: A beta 1-adrenoceptor partial agonist. Br J Pharmacol 77:381-388
112. Oral H, Chugh A, Scharf C, Hall B, Cheung P, Veerareddy S, Daneshvar GF, Pelosi F Jr, Morady F (2004) Pulmonary vein isolation for vagotonic, adrenergic, and random episodes of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 15:402-406
113. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334:1349-1355
114. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651-1658
115. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, Salvati A, Dicandia C, Mazzone P, Santinelli V, Gulletta S, Chierchia S (2000) Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 102:2619-2628
116. Plank DM, Yatani A, RitsuH, Witt S, Glascock B, Lalli MJ, PeriasamyM, Fiset C, Benkusky N, Valdivia HH, Sussman MA (2003) Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade. Am J Physiol Heart Circ Physiol 285:H305-H315
117. Pogwizd SM, BersDM (2004) Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med 14:61-66
118. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, MetraM, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol OrMetoprolol European Trial (COMET): randomised controlled trial. Lancet 362:7-13
119. Priori SG, Napolitano C (2004) Genetics of cardiac arrhythmias and sudden cardiac death. Ann N Y Acad Sci 1015:96-110
120. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA (2001)Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103:196-200
121. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455-2461
122. Reddy P (2001) Does prophylaxis against atrial fibrillation after cardiac surgery reduce length of stay or hospital costs? Pharmacotherapy 21:338-344
123. Reiter MJ (2002) Beta-adrenergic blocking drugs as antifibrillatory agents. Curr Cardiol Rep 4:426-433
124. Reiter MJ, Reiffel JA (1998) Importance of beta blockade in the therapy of serious ventricular arrhythmias. Am J Cardiol 82:9I-19I
125. Rodefeld MD, Beau SL, Schuessler RB, Boineau JP, Saffitz JE (1996) Beta-adrenergic and muscarinic cholinergic receptor densities in the human sinoatrial node: identification of a high beta 2-adrenergic receptor density. J Cardiovasc Electrophysiol 7:1039-1049
126. Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013-1022
127. Rosati B, Grau F, Rodriguez S, Li H, Nerbonne JM, McKinnon D (2003) Concordant expression of KChIP2 mRNA, protein and transient outward current throughout the canine ventricle. J Physiol 548:815-822
128. Rossner KL, Sachs HG (1978) Electrophysiological study of Syrian hamster hereditary cardiomyopathy. Cardiovasc Res 12:436-443
129. Ryden L, Ariniego R, Arnman K, Herlitz J, Hjalmarson A, Holmberg S, Reyes C, Smedgard P, Svedberg K, Vedin A, Waagstein F, Waldenstrom A, Wilhelmsson C, Wedel H, Yamamoto M (1983) A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med 308:614-618
130. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT (1996) Coassembly of K (V)LQT1 and minK (IsK) proteins to form cardiac I (Ks) potassium channel. Nature 384:80-83
131. Schafers RF, Poller U, Ponicke K, Geissler M, Daul AE, Michel MC, Brodde OE (1997) Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine. Naunyn Schmiedebergs Arch Pharmacol 355:239-249
132. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89-95
133. Shand DG (1983) Clinical pharmacology of the beta-blocking drugs: implications for the postinfarction patient. Circulation 67:I2-I5
134. Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K, Suyama K, Aihara N, Kamakura S, Sunagawa K, Echigo S, Nakamura K, OheT, Towbin JA, Napolitano C, Priori SG (2003) Epinephrine unmasks latentmutation carrierswith LQT1 formof congenital long- QT syndrome. J Am Coll Cardiol 41:633-642
135. Sicouri S, Antzelevitch C (1995) Electrophysiologic characteristics of M cells in the canine left ventricular free wall. J Cardiovasc Electrophysiol 6:591-603
136. Singh BN, Vaughan Williams EM (1970) A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol 39:675-687
137. Sinno H, Derakhchan K, Libersan D, Merhi Y, Leung TK, Nattel S (2003) Atrial ischemia promotes atrial fibrillation in dogs. Circulation 107:1930-1936
138. Sneader W (2001) The discovery and synthesis of epinephrine. Drug News Perspect 14:491-494
139. Soriano JB, Hoes AW, Meems L, Grobbee DE (1997) Increased survival with beta-blockers: importance of ancillary properties. Prog Cardiovasc Dis 39:445-456
140. St John SM, Ferrari VA (2002) Prevention of left ventricular remodeling after myocardial infarction. Curr Treat Options Cardiovasc Med 4:97-108
141. Steinfath M, Danielsen W, von der LH, Mende U, Meyer W, Neumann J, Nose M, Reich T, SchmitzW, ScholzH (1992)Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Br J Pharmacol 105:463-469
142. Stengl M, Volders PG, Thomsen MB, Spatjens RL, Sipido KR, Vos MA (2003) Accumulation of slowly activating delayed rectifier potassium current (IKs) in canine ventricular myocytes. J Physiol 551:777-786
143. SumitomoN, Harada K, NagashimaM, YasudaT, NakamuraY, AragakiY, SaitoA, KurosakiK, Jouo K, KoujiroM, Konishi S, Matsuoka S, OonoT, Hayakawa S, Miura M, Ushinohama H, Shibata T, Niimura I (2003) Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 89:66-70
144. Thomas D, Zhang W, Karle CA, Kathofer S, Schols W, Kubler W, Kiehn J (1999) Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A. J Biol Chem 274:27457-27462
145. Tromba C, Cohen IS (1990)Anovel action of isoproterenol to inactivate a cardiacK+current is not blocked by beta and alpha adrenergic blockers. Biophys J 58:791-795
146. Ullman A, Svedmyr N (1988) Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 43:674-678
147. Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ (1993) Altered expression of betaadrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87:454-463
148. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl JMed 347:1834-1840
149. Viatchenko-Karpinski S, Terentyev D, Gyorke I, Terentyeva R, Volpe P, Priori SG, Napolitano C, Nori A, Williams SC, Gyorke S (2004) Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res 94:471-477
150. Volders PG, SipidoKR, Carmeliet E, Spatjens RL, WellensHJ, Vos MA (1999)RepolarizingK+ currents ITO1 and IKs are larger in right than left canine ventricular midmyocardium. Circulation 99:206-210
151. Volders PG, Stengl M, van Opstal JM, Gerlach U, Spatjens RL, Beekman JD, Sipido KR, Vos MA (2003) Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation. Circulation 107:2753-2760
152. Vos MA, Gorgels AP, Leunissen JD, Wellens HJ (1990) Flunarizine allows differentiation between mechanisms of arrhythmias in the intact heart. Circulation 81:343-349
153. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 342:1441-1446
154. Wainger BJ, DeGennaro M, Santoro B, Siegelbaum SA, Tibbs GR (2001) Molecular mechanism of cAMP modulation of HCN pacemaker channels. Nature 411:805-810
155. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. SurvivalWith Oral d-Sotalol. Lancet 348:7-12
156. Walsh KB, Kass RS (1991) Distinct voltage-dependent regulation of a heart-delayed IK by protein kinases A and C. Am J Physiol 261:C1081-C1090
157. Wang Z, Fermini B, Nattel S (1993) Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1 cloned channel currents. Circ Res 73:1061-1076
158. Warth JD, Collier ML, Hart P, Geary Y, Gelband CH, Chapman T, Horowitz B, Hume JR (1996) CFTR chloride channels in human and simian heart. Cardiovasc Res 31:615-624
159. Wettwer E, Amos GJ, Posival H, Ravens U (1994) Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ Res 75:473-482
160. Wiederhold KF, Nilius B (1986) Increased sensitivity of ventricular myocardium to intracellular calcium-overload in Syrian cardiomyopathic hamster. Biomed Biochim Acta 45:1333-1337
161. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954-1968
162. Wilde AA, RodenDM (2000) Predicting the long-QT genotype fromclinical data: fromsense to science. Circulation 102:2796-2798
163. Williams RS, Bishop T (1981) Selectivity of dobutamine for adrenergic receptor subtypes: in vitro analysis by radioligand binding. J Clin Invest 67:1703-1711
164. Wischmeyer E, Karschin A (1996) Receptor stimulation causes slow inhibition of IRK1 inwardly rectifying K+ channels by direct protein kinase A-mediated phosphorylation. Proc Natl Acad Sci U S A 93:5819-5823
165. Wit AL, Cranefield PF (1976) Triggered activity in cardiacmuscle fibers of the simian mitral valve. Circ Res 38:85-98
166. Wit AL, Cranefield PF (1977) Triggered and automatic activity in the canine coronary sinus. Circ Res 41:434-445
167. Woelfel A, Foster JR, Simpson RJ Jr, Gettes LS (1984) Reproducibility and treatment of exercise-induced ventricular tachycardia. Am J Cardiol 53:751-756
168. Workman AJ, Kane KA, Russell JA, Norrie J, Rankin AC (2003) Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res 58:518-525
169. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-1833
170. Xiao YF, McArdle JJ (1995) Activation of protein kinase A partially reverses the effects of 2, 3-butanedione monoxime on the transient outward K+ current of rat ventricular myocytes. Life Sci 57:335-343
171. Yasumura Y, Takemura K, Sakamoto A, Kitakaze M, Miyatake K (2003) Changes in myocardial gene expression associated with beta-blocker therapy in patients with chronic heart failure. J Card Fail 9:469-474
172. Yue L, Melnyk P, Gaspo R, Wang Z, Nattel S (1999)Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 84:776-784
173. Yusuf S, PetoR, Lewis J, CollinsR, Sleight P (1985)Beta blockade during and aftermyocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335-371
174. Zhang LM, Wang Z, Nattel S (2002) Effects of sustained beta-adrenergic stimulation on ionic currents of cultured adult guinea pig cardiomyocytes. Am J Physiol Heart Circ Physiol 282:H880-H889
175. Zipes DP, Arbel E, Knope RF, Moe GK (1974) Accelerated cardiac escape rhythms caused by ouabain intoxication. Am J Cardiol 33:248-253